Suzhou Ribo Life Science’s $40 Million Series E1 Financing Round

Laura Testa
Tagged:

Kirkland & Ellis advised Suzhou Ribo Life Science Co., Ltd. on the transaction.Suzhou Ribo Life Science Co., Ltd. (Ribo), a clinical stage company developing innovative RNAi…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here